SAVA - Cassava Sciences: A 'Moon Shot' Becomes A Bigger 'Long Shot'
2024-07-02 12:18:09 ET
Summary
- Today, we take a look at Cassava Sciences, Inc., which has a late-stage candidate targeting Alzheimer's, for the first time since late 2022.
- There has been a great deal of news flow around this controversial and high-risk/high-reward small-cap concern recently.
- An updated analysis around Cassava Sciences follows in the paragraphs below.
Today, we put Cassava Sciences, Inc. ( SAVA ) in the spotlight for the first time since our last article on this developmental concern late in 2022. The controversial small-cap concern has been in the news recently and few stocks this size bring out such passion for investors (both bulls and bears), which can be seen by the huge number of comments every time a piece ( I , II , III ) is posted around Cassava here on Seeking Alpha....
Cassava Sciences: A 'Moon Shot' Becomes A Bigger 'Long Shot'